Pancreatic cancer is deadly and difficult to treat. A new pill could change that
The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
Original Source
Read the full article at Pbs →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.